1. Home
  2. ONC vs CARR Comparison

ONC vs CARR Comparison

Compare ONC & CARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BeiGene Ltd. American Depositary Shares

ONC

BeiGene Ltd. American Depositary Shares

N/A

Current Price

$416.47

Market Cap

40.6B

Sector

Health Care

ML Signal

N/A

Logo Carrier Global Corporation

CARR

Carrier Global Corporation

N/A

Current Price

$54.28

Market Cap

44.7B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ONC
CARR
Founded
2010
2019
Country
Switzerland
United States
Employees
12000
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
40.6B
44.7B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ONC
CARR
Price
$416.47
$54.28
Analyst Decision
Strong Buy
Buy
Analyst Count
27
26
Target Price
★ $465.00
$68.70
AVG Volume (30 Days)
442.0K
★ 6.4M
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
★ 1.77%
EPS Growth
★ 140.43
N/A
EPS
★ 0.56
N/A
Revenue
$238,387,000.00
★ $21,747,000,000.00
Revenue This Year
$29.05
$9.50
Revenue Next Year
$15.06
$6.25
P/E Ratio
$743.85
★ N/A
Revenue Growth
★ 22179.16
N/A
52 Week Low
$253.95
$50.24
52 Week High
$424.73
$76.76

Technical Indicators

Market Signals
Indicator
ONC
CARR
Relative Strength Index (RSI) 67.27 45.64
Support Level $341.67 $53.91
Resistance Level N/A $57.16
Average True Range (ATR) 10.70 1.77
MACD 4.37 -0.05
Stochastic Oscillator 88.77 32.01

Price Performance

Historical Comparison
ONC
CARR

About ONC BeiGene Ltd. American Depositary Shares

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.

About CARR Carrier Global Corporation

Carrier Global, spun out of United Technologies in 2020, manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its flagship Carrier brand, as well as Bryant, Payne, Heil, and others across various price points. In 2024, Carrier acquired Viessmann Climate Solutions to expand its footprint in Europe with heat pumps, boilers, and solar PV equipment. Proceeds from the sale of Carrier's fire and security (Honeywell) and commercial refrigeration (Haier) businesses reduced debt and focused the company on global HVAC and refrigeration solutions. Carrier generates 75% of sales from equipment and 25% from parts and services. The company derives 50% of revenue from the US, 30% from Europe, and 20% from the Asia-Pacific region.

Share on Social Networks: